DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Conditions:   Venous Thromboembolism;   Deep Venous Thrombosis;   Post-Thrombotic Syndrome Interventions:   Device: ClotTriever System;   Drug: Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc. Sponsor:   Inari Medical Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2023 Category: Research Source Type: clinical trials